- Home
- / Speratum
Speratum
Total Funding
$2.8 M
Speratum Summary
Company Summary
- Overview
- Speratum is a biotechnology company developing targeted molecular therapies for the treatment of cancer. Its lead candidate is a microRNA therapy against pancreatic cancer.
- Type
- Private
- Status
- Active
- Founded
- 2014
- Website
- https://www.speratum.com/
- Cybersecurity rating
Table of Contents
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026